Drug Development Research

SJR Rank #7,352H-index: 76SJR: 0.765Best quartile: Q2APC: US$3,980
Journal website: aims, scope and author guidelines
Publisher

John Wiley & Sons Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Drug DiscoveryQ2

Areas: Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorAdenosine and Purinergic SignalingCholinesterase and Neurodegenerative DiseasesIon channel regulation and functionComputational Drug Discovery MethodsChemical synthesis and alkaloidsCardiac electrophysiology and arrhythmiasNeuropeptides and Animal Physiology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

0272-4391, 1098-2299

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

4.42

References per Document

69.07

Coverage

1981-2026

Scope

Drug Development Research publishes research papers and review-type articles covering all area within drug development: from target identification and validation and structure–activity relationship studies, through to post-market clinical reports. Topics covered include but are not limited to medicinal and process chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, drug delivery, formulation, pharmacokinetics, clinical trial reviews and post-approval/post-marketing evaluation. The journal also welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy and strategy, and regulatory issues that involve drug discovery and development.

Metrics from SCImago Journal Rank 2025. View on SCImago